VAS
ANIP icon

Vestmark Advisory Solutions’s ANI Pharmaceuticals ANIP Stock Holding History

Vestmark Advisory Solutions’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.36M Sell
16,440
-348
-2% -$27.9K 0.01% 871
2026
Q1 		$1.29M Buy
16,788
+5,398
+47% +$421K 0.01% 795
2025
Q4 		$899K Buy
+11,390
New +$986K 0.01% 835

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vestmark Advisory Solutions's ANIP Position: Q2 2026 in Review

Vestmark Advisory Solutions reduced its ANI Pharmaceuticals (ANIP) stake by 2.1% in Q2 2026, selling an estimated $27.9K and leaving 16,440 shares worth $1.36M. The position accounts for 0.01% of the portfolio, ranked #871.

Vestmark Advisory Solutions first reported a position in ANIP in Q4 2025 and has held it in 3 quarters since. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Vestmark Advisory Solutions held 16,440 shares of ANI Pharmaceuticals worth $1.36M as of Q2 2026.
  • Vestmark Advisory Solutions sold 348 ANI Pharmaceuticals shares in Q2 2026, an estimated $27.9K.
  • ANI Pharmaceuticals made up 0.01% of Vestmark Advisory Solutions's portfolio in Q2 2026, its #871 holding.
  • Vestmark Advisory Solutions first reported a position in ANI Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Vestmark Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.